Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2019

Open Access 01-12-2019 | Naloxone | Research

Factors associated with willingness to wear an electronic overdose detection device

Authors: Keith Ahamad, Huiru Dong, Cheyenne Johnson, Kanna Hyashi, Kora DeBeck, M. J. Milloy, Evan Wood

Published in: Addiction Science & Clinical Practice | Issue 1/2019

Login to get access

Abstract

Background

North America is in the midst of an opioid overdose epidemic. Although take-home naloxone and other measures have been an effective strategy to reduce overdoses, many events are unwitnessed and mortality remains high amongst those using drugs alone. While wearable devices that can detect and alert others of an overdose are being developed, willingness of people who use drugs to wear such a device has not been described.

Methods

Drug using persons enrolled in a community-recruited cohort in Vancouver, Canada, were asked whether or not they would be willing to wear a device against their skin that would alert others in the event of an overdose. Logistic regression was used to identify factors independently associated with willingness to wear such a device.

Results

Among the 1061 participants surveyed between December 2017 and May 2018, 576 (54.3%) were willing to wear an overdose detection device. Factors independently associated with willingness included ever having overdosed (adjusted odds ratio [AOR] = 1.39, 95% confidence interval [CI] 1.06–1.83), current methadone treatment (AOR = 1.86, 95% CI 1.45–2.40), female gender AOR = 1.41, 95% CI 1.09–1.84) and a history of chronic pain (AOR = 1.53, 95% CI 1.19–1.96). Whereas homelessness (AOR = 0.67, 95% CI 0.50–0.91) was negatively associated with willingness.

Conclusions

A high level of willingness to wear an overdose detection device was observed in this setting and a range of factors associated with overdose were positively associated with willingness. Since some factors, such as homelessness may be a barrier, further research is needed to investigate explanations for unwillingness and to evaluate real world acceptability of a wearable overdose detection devices as this technology becomes available.
Literature
1.
go back to reference Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2016. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017. Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2016. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017.
2.
go back to reference Coroner OotC. Fentanyl-detected illicit drug overdose deaths January 1, 2012 to June 30, 2018. In: General MoPSaS, editor. August 2, 2018. Coroner OotC. Fentanyl-detected illicit drug overdose deaths January 1, 2012 to June 30, 2018. In: General MoPSaS, editor. August 2, 2018.
3.
go back to reference Coroner OotC. Illicit drug overdose deaths in BC January 1, 2008–June 30, 2018. In: General MoPSS, editor. August 2, 2018. Coroner OotC. Illicit drug overdose deaths in BC January 1, 2008–June 30, 2018. In: General MoPSS, editor. August 2, 2018.
4.
go back to reference Hoilett OS, Twibell AM, Srivastava R, Linnes JC, editors. Kick LL: A Smartwatch for Monitoring Respiration and Heart Rate using Photoplethysmography. In: 40th Annual international conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE; 2018. Hoilett OS, Twibell AM, Srivastava R, Linnes JC, editors. Kick LL: A Smartwatch for Monitoring Respiration and Heart Rate using Photoplethysmography. In: 40th Annual international conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE; 2018.
5.
go back to reference Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.CrossRef Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.CrossRef
6.
go back to reference Tzemis D, Al-Qutub D, Amlani A, Kesselring S, Buxton JA. A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open. 2014;2(3):E153.CrossRef Tzemis D, Al-Qutub D, Amlani A, Kesselring S, Buxton JA. A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open. 2014;2(3):E153.CrossRef
7.
go back to reference Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–6.CrossRef Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–6.CrossRef
8.
go back to reference Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N Engl J Med. 2017;377(4):391–4.CrossRef Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N Engl J Med. 2017;377(4):391–4.CrossRef
9.
go back to reference Nandakumar R, Gollakota S, Sunshine JE. Opioid overdose detection using smartphones. Sci Transl Med. 2019;11(474):eaau8914.CrossRef Nandakumar R, Gollakota S, Sunshine JE. Opioid overdose detection using smartphones. Sci Transl Med. 2019;11(474):eaau8914.CrossRef
10.
go back to reference Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–65.CrossRef Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–65.CrossRef
11.
go back to reference Tyndall MW, Currie S, Spittal P, Li K, Wood E, O’Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887–93.CrossRef Tyndall MW, Currie S, Spittal P, Li K, Wood E, O’Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887–93.CrossRef
12.
go back to reference Hadland SE, Marshall BD, Kerr T, Zhang R, Montaner JS, Wood E. A comparison of drug use and risk behavior profiles among younger and older street youth. Subst Use Misuse. 2011;46(12):1486–94.CrossRef Hadland SE, Marshall BD, Kerr T, Zhang R, Montaner JS, Wood E. A comparison of drug use and risk behavior profiles among younger and older street youth. Subst Use Misuse. 2011;46(12):1486–94.CrossRef
13.
go back to reference Kerr T, Marshall BD, Miller C, Shannon K, Zhang R, Montaner JS, et al. Injection drug use among street-involved youth in a Canadian setting. BMC Public Health. 2009;9:171.CrossRef Kerr T, Marshall BD, Miller C, Shannon K, Zhang R, Montaner JS, et al. Injection drug use among street-involved youth in a Canadian setting. BMC Public Health. 2009;9:171.CrossRef
14.
go back to reference Caudarella A, Dong H, Milloy M, Kerr T, Wood E, Hayashi KJD, et al. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51–5.CrossRef Caudarella A, Dong H, Milloy M, Kerr T, Wood E, Hayashi KJD, et al. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51–5.CrossRef
15.
go back to reference Strang JJA. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths. Addiction. 2015;110:27–35.CrossRef Strang JJA. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths. Addiction. 2015;110:27–35.CrossRef
16.
go back to reference Pierce M, Bird SM, Hickman M, Marsden J, Dunn G, Jones A, et al. Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England. Addiction. 2016;111(2):298–308.CrossRef Pierce M, Bird SM, Hickman M, Marsden J, Dunn G, Jones A, et al. Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England. Addiction. 2016;111(2):298–308.CrossRef
17.
go back to reference Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr TJTL. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429–37.CrossRef Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr TJTL. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429–37.CrossRef
18.
go back to reference Kerr T, Mitra S, Kennedy MC, McNeil R. Supervised injection facilities in Canada: past, present, and future. Harm Reduct J. 2017;14(1):28.CrossRef Kerr T, Mitra S, Kennedy MC, McNeil R. Supervised injection facilities in Canada: past, present, and future. Harm Reduct J. 2017;14(1):28.CrossRef
19.
go back to reference Macdonald R. Implantable device and methods for reversing overdose of a substance. Google Patents; 2018. Macdonald R. Implantable device and methods for reversing overdose of a substance. Google Patents; 2018.
20.
go back to reference Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, et al. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007;91(Supplement 1):S4–17.CrossRef Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, et al. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007;91(Supplement 1):S4–17.CrossRef
21.
go back to reference Rotondi NK, Strike C, Kolla G, Rotondi MA, Rudzinski K, Guimond T, et al. Transition to injection drug use: the role of initiators. AIDS Behav. 2014;18:486–94.CrossRef Rotondi NK, Strike C, Kolla G, Rotondi MA, Rudzinski K, Guimond T, et al. Transition to injection drug use: the role of initiators. AIDS Behav. 2014;18:486–94.CrossRef
22.
go back to reference Chen YH, McFarland W, Raymond HF. Risk behaviors for HIV in sexual partnerships of San Francisco injection drug users. AIDS Care. 2013;26:554–8.CrossRef Chen YH, McFarland W, Raymond HF. Risk behaviors for HIV in sexual partnerships of San Francisco injection drug users. AIDS Care. 2013;26:554–8.CrossRef
23.
go back to reference Palepu A, Marshall BD, Lai C, Wood E, Kerr T. Addiction treatment and stable housing among a cohort of injection drug users. PLoS ONE. 2010;5(7):e11697.CrossRef Palepu A, Marshall BD, Lai C, Wood E, Kerr T. Addiction treatment and stable housing among a cohort of injection drug users. PLoS ONE. 2010;5(7):e11697.CrossRef
24.
go back to reference Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353(9165):1657–61.CrossRef Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353(9165):1657–61.CrossRef
25.
go back to reference DeBeck K, Kerr T, Lai C, Buxton J, Montaner J, Wood E, et al. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 2012;38(1):55–62.CrossRef DeBeck K, Kerr T, Lai C, Buxton J, Montaner J, Wood E, et al. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 2012;38(1):55–62.CrossRef
26.
go back to reference Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, et al. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med. 2005;29(2):126–30.CrossRef Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, et al. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med. 2005;29(2):126–30.CrossRef
Metadata
Title
Factors associated with willingness to wear an electronic overdose detection device
Authors
Keith Ahamad
Huiru Dong
Cheyenne Johnson
Kanna Hyashi
Kora DeBeck
M. J. Milloy
Evan Wood
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2019
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-019-0153-5

Other articles of this Issue 1/2019

Addiction Science & Clinical Practice 1/2019 Go to the issue